Income Statement Stemtech Corporation

Stocks

STEK

US85859W1027

Pharmaceuticals

Market Closed - OTC Markets 01:25:43 11/09/2026 am IST			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	-87.50%

15/08	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
23/06	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

27451583db95d0dc.b9UJ8lZOL3lbJT7hgFdbSoaCEy57f5KGjZ6Dol_VDtg.WblswRIRfBxqbVmT5hIPHu7gIx4uGKG0_9Ha9wu2P5opgHudOwZeP2lJDg

Published financial data: STEMTECH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	43.21L	45.59L	49.22L	50.54L	28.76L
Total Revenues	43.21L	45.59L	49.22L	50.54L	28.76L
Cost of Goods Sold, Total	10.23L	11.64L	10.02L	13.26L	6L
Gross Profit	32.98L	33.95L	39.2L	37.27L	23.09L
Selling General & Admin Expenses, Total	65.08L	84.19L	81.31L	61.14L	50.18L
R&D Expenses	-	-	13.8T	-	-
Other Operating Expenses, Total	65.08L	84.19L	81.44L	61.14L	50.18L
Operating Income	-32.1L	-50.23L	-42.25L	-23.86L	-27.09L
Interest Expense, Total	-83.3L	-40.98L	-48.93L	-15.79L	-14.52L
Net Interest Expenses	-83.3L	-40.98L	-48.93L	-15.79L	-14.52L
Other Non Operating Income (Expenses)	44.29L	-32.15L	15.05L	85.36T	1L
EBT, Excl. Unusual Items	-71.11L	-1.23Cr	-76.12L	-38.8L	-40.5L
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-	37.99L	21.8L	1L	-
EBT, Incl. Unusual Items	-71.11L	-85.37L	-54.32L	-37.73L	-40.5L
Income Tax Expense	-	95.62T	-	-	-
Earnings From Continuing Operations	-71.11L	-86.33L	-54.32L	-37.73L	-40.5L
Net Income to Company	-71.11L	-86.33L	-54.32L	-37.73L	-40.5L
Minority Interest	33.65T	87.9T	1.73T	3.14T	3.14T
Net Income - (IS)	-70.77L	-85.45L	-54.3L	-37.7L	-40.47L
Net Income to Common Incl Extra Items	-70.77L	-85.45L	-54.3L	-37.7L	-40.47L
Net Income to Common Excl. Extra Items	-70.77L	-85.45L	-54.3L	-37.7L	-40.47L
Per Share Items
Net EPS - Basic	-0.19	-0.19	-0.07	-0.03	-0.02
Basic EPS - Continuing Operations	-0.19	-0.19	-0.07	-0.03	-0.02
Basic Weighted Average Shares Outstanding	3.76Cr	4.6Cr	8.35Cr	12Cr	17Cr
Net EPS - Diluted	-0.19	-0.19	-0.07	-0.03	-0.02
Diluted EPS - Continuing Operations	-0.19	-0.19	-0.07	-0.03	-0.02
Diluted Weighted Average Shares Outstanding	3.76Cr	4.6Cr	8.35Cr	12Cr	17Cr
Normalized Basic EPS	-0.12	-0.17	-0.06	-0.02	-0.01
Normalized Diluted EPS	-0.12	-0.17	-0.06	-0.02	-0.01
Supplemental Items
EBITDA	-27.82L	-31.18L	-36.37L	-20.42L	-25.42L
EBITA	-32.1L	-35.66L	-42.25L	-23.86L	-27.09L
EBIT	-32.1L	-50.23L	-42.25L	-23.86L	-27.09L
EBITDAR	-26.76L	-30.33L	-35.63L	-	-
Effective Tax Rate - (Ratio)	-	-1.12	-	-	-
Normalized Net Income	-44.11L	-76.22L	-47.56L	-24.22L	-25.28L
Supplemental Operating Expense Items
Selling and Marketing Expenses	17.55L	15.81L	16.91L	9L	5L
General and Administrative Expenses	47.54L	68.38L	64.4L	52.34L	45.54L
Research And Development Expense From Footnotes	-	-	13.8T	-	-
Net Rental Expense, Total	1L	85.63T	73.31T	-	-
Imputed Operating Lease Interest Expense	60.22L	20.52L	11.52L	-	-
Imputed Operating Lease Depreciation	-59.16L	-19.67L	-10.79L	-	-
Stock-Based Comp., Other (Total)	10.31L	39.96L	9L	11.87L	15.66L
Total Stock-Based Compensation	10.31L	39.96L	9L	11.87L	15.66L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	8L	1L	1L	3L	2L
Total Cash And Short Term Investments	8L	1L	1L	3L	2L
Accounts Receivable, Total	10.72T	34.77T	61.49T	3L	-
Total Receivables	10.72T	34.77T	61.49T	3L	-
Inventory	4L	2L	48.32T	2L	2L
Prepaid Expenses	3L	3L	2L	2L	1.48T
Total Current Assets	16L	6L	4L	9L	5L
Gross Property Plant And Equipment	4L	-	-	-	-
Accumulated Depreciation	-2L	-	-	-	-
Net Property Plant And Equipment	2L	2L	80.88T	-	-
Goodwill	5L	5L	5L	5L	5L
Other Intangibles, Total	34.07L	29.94L	27.11L	23.76L	22.09L
Other Long-Term Assets, Total	38.69T	23.06T	23.71T	16.93T	16.48T
Total Assets	57.2L	42.67L	36.83L	37.82L	31.5L
Liabilities
Accounts Payable, Total	40.51L	27.95L	23.7L	41.92L	53.64L
Accrued Expenses, Total	-	1L	72.15T	59.32T	45.79T
Short-term Borrowings	10.38L	11.32L	36.3L	44.89L	50.05L
Current Portion of Long-Term Debt	18.12T	11.25T	-	-	-
Current Portion of Leases	55.74T	1L	66.87T	-	-
Unearned Revenue Current, Total	-	39.17T	56.04T	1.46T	2L
Other Current Liabilities	42.25L	31.71L	3L	3L	-
Total Current Liabilities	93.87L	74.16L	64.62L	90.09L	1.06Cr
Long-Term Debt	2L	-	-	-	-
Long-Term Leases	1L	23.07T	-	-	-
Other Non Current Liabilities	-	-	-	-	3L
Total Liabilities	97.26L	74.39L	64.62L	90.09L	1.09Cr
Common Stock, Total	44.68T	53.44T	1L	1L	4L
Additional Paid In Capital	1.01Cr	1.94Cr	2.47Cr	2.64Cr	2.76Cr
Retained Earnings	-1.31Cr	-2.16Cr	-2.71Cr	-3.08Cr	-3.49Cr
Comprehensive Income and Other	-4L	-2L	2L	-1L	-1L
Total Common Equity	-33.56L	-24.34L	-20.39L	-44.84L	-69.59L
Minority Interest	-6L	-7L	-7L	-7L	-7L
Total Equity	-40.05L	-31.72L	-27.79L	-52.27L	-77.04L
Total Liabilities And Equity	57.2L	42.67L	36.83L	37.82L	31.5L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.47Cr	6.47Cr	12Cr	14Cr	206.8Cr
ECS Total Common Shares Outstanding	4.47Cr	5.34Cr	10Cr	14Cr	43Cr
Book Value / Share	-0.08	-0.05	-0.02	-0.03	-0.02
Tangible Book Value	-72.3L	-58.96L	-52.17L	-73.28L	-96.35L
Tangible Book Value Per Share	-0.16	-0.11	-0.05	-0.05	-0.02
Total Debt	14.5L	12.86L	36.97L	44.89L	50.05L
Net Debt	6L	11.53L	35.83L	42.34L	47.67L
Debt Equivalent Oper. Leases	8L	7L	6L	-	-
Minority Interest, Total (Incl. Fin. Div)	-6L	-7L	-7L	-7L	-7L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2L	54.76T	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	2L	1L	48.32T	2L	2L
Machinery, Total	-	-	-	-	-
Full Time Employees	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-70.77L	-85.45L	-54.3L	-37.7L	-40.47L
Depreciation & Amortization - CF	4L	4L	7L	4L	2L
Amortization of Goodwill and Intangible Assets - (CF)	-	14.58L	-	-	-
Depreciation & Amortization, Total	4L	19.05L	7L	4L	2L
Amortization of Deferred Charges, Total - (CF)	6L	24.29L	27.97L	4L	56.06T
Stock-Based Compensation (CF)	10.31L	39.96L	9L	11.87L	15.66L
Other Operating Activities, Total	21.27L	-7L	-20.47L	-2L	-3.14T
Change In Accounts Receivable	15.1T	-24.05T	-26.73T	-2L	3L
Change In Inventories	-2L	3L	1L	-1L	-19.98T
Change In Accounts Payable	12.18L	-7L	10L	18.09L	11.59L
Change in Unearned Revenues	-	39.17T	16.87T	-54.58T	2L
Change in Other Net Operating Assets	-21.73T	53.27T	34.43T	-15.84T	2L
Cash from Operations	-19.14L	-12.17L	-20.36L	-6L	-5L
Capital Expenditure	-	-	-	-	-
Cash from Investing	-	-	-	-	-
Short Term Debt Issued, Total	-	2L	22.36L	9L	5L
Long-Term Debt Issued, Total	33.22L	6L	-	-	-
Total Debt Issued	33.22L	8L	22.36L	9L	5L
Short Term Debt Repaid, Total	-35T	-	-7L	-3L	-
Long-Term Debt Repaid, Total	-7L	-6L	-	-	-
Total Debt Repaid	-7L	-6L	-7L	-3L	-
Issuance of Common Stock	-	1L	-	5L	-
Cash from Financing	26.29L	3L	15.79L	10.79L	5L
Foreign Exchange Rate Adjustments	-19.5T	2L	4L	-3L	6.52T
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	7L	-7L	-18.32T	1L	-17.05T
Supplemental Items
Cash Interest Paid	-	36.2T	6.82T	6.82T	-
Levered Free Cash Flow	-59.6T	8L	-45.43L	9L	10L
Unlevered Free Cash Flow	45.44L	9L	-42.83L	14.85L	18.17L
Change In Net Working Capital	-50.91L	18.3L	31.95L	-13.75L	-17.77L
Net Debt Issued / Repaid	26.29L	2L	15.79L	6L	5L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-37.4	-62.87	-66.42	-39.96	-48.85
Return on Total Capital	1.01T	141.37	545.48	-1.65T	98.53
Return On Equity %	519.54	240.56	182.57	94.25	62.64
Return on Common Equity	962.01	295.17	242.78	115.57	70.73
Margin Analysis
Gross Profit Margin %	76.32	74.47	79.65	73.75	80.29
SG&A Margin	150.61	184.65	165.21	120.98	174.47
EBITDA Margin %	-64.37	-68.4	-73.89	-40.41	-88.36
EBITA Margin %	-74.29	-78.21	-85.84	-47.22	-94.18
EBIT Margin %	-74.29	-110.18	-85.84	-47.22	-94.18
Income From Continuing Operations Margin %	-164.56	-189.34	-110.37	-74.65	-140.8
Net Income Margin %	-163.78	-187.41	-110.34	-74.59	-140.69
Net Avail. For Common Margin %	-163.78	-187.41	-110.34	-74.59	-140.69
Normalized Net Income Margin	-102.07	-167.18	-96.64	-47.93	-87.89
Levered Free Cash Flow Margin	-1.38	17.52	-92.32	17.03	33.55
Unlevered Free Cash Flow Margin	105.15	20.43	-87.02	29.39	63.16
Asset Turnover
Asset Turnover	0.81	0.91	1.24	1.35	0.83
Fixed Assets Turnover	25.93	24.16	39.22	-	-
Receivables Turnover (Average Receivables)	236.51	200.47	102.25	30.51	-
Inventory Turnover (Average Inventory)	3.22	3.92	9.71	10.8	2.73
Short Term Liquidity
Current Ratio	0.17	0.08	0.06	0.1	0.04
Quick Ratio	0.09	0.02	0.03	0.06	0.02
Operating Cash Flow to Current Liabilities	-0.2	-0.16	-0.32	-0.07	-0.05
Days Sales Outstanding (Average Receivables)	1.54	1.82	3.57	11.99	-
Days Outstanding Inventory (Average Inventory)	113.27	93.2	37.6	33.9	133.49
Average Days Payable Outstanding	999.2	1.35T	1.02T	821.99	2.99T
Cash Conversion Cycle (Average Days)	-884.39	-1.25T	-981.95	-776.09	-
Long Term Solvency
Total Debt/Equity	-36.21	-40.53	-133.05	-85.89	-64.97
Total Debt / Total Capital	-56.75	-68.15	402.59	-608.61	-185.44
LT Debt/Equity	-8.45	-0.73	-	-	-
Long-Term Debt / Total Capital	-13.25	-1.22	-	-	-
Total Liabilities / Total Assets	170.02	174.34	175.44	238.19	344.61
EBIT / Interest Expense	-0.39	-1.23	-0.86	-1.51	-1.87
EBITDA / Interest Expense	-0.32	-0.74	-0.73	-1.25	-1.75
(EBITDA - Capex) / Interest Expense	-0.32	-0.74	-0.73	-1.25	-1.75
Total Debt / EBITDA	-0.54	-0.42	-1.04	-2.28	-1.97
Net Debt / EBITDA	-0.23	-0.38	-1.01	-2.15	-1.88
Total Debt / (EBITDA - Capex)	-0.54	-0.42	-1.04	-2.28	-1.97
Net Debt / (EBITDA - Capex)	-0.23	-0.38	-1.01	-2.15	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.44	5.51	7.94	2.69	-43.08
Gross Profit, 1 Yr. Growth %	-10.12	2.95	15.45	-4.91	-38.04
EBITDA, 1 Yr. Growth %	177.75	12.11	16.62	-43.85	24.47
EBITA, 1 Yr. Growth %	124.21	11.08	18.47	-43.51	13.52
EBIT, 1 Yr. Growth %	124.21	56.48	-15.9	-43.51	13.52
Earnings From Cont. Operations, 1 Yr. Growth %	311.6	21.4	-37.08	-30.55	7.35
Net Income, 1 Yr. Growth %	672.06	20.73	-36.45	-30.58	7.35
Normalized Net Income, 1 Yr. Growth %	2.07T	72.81	-37.61	-49.07	4.37
Diluted EPS Before Extra, 1 Yr. Growth %	93.07	-5.2	-63.16	-54.63	-24.96
Accounts Receivable, 1 Yr. Growth %	-58.49	224.32	76.87	338.66	-
Inventory, 1 Yr. Growth %	119.71	-63.78	-69.42	308.39	10.13
Net Property, Plant and Equip., 1 Yr. Growth %	64.5	-17.93	-52.45	-	-
Total Assets, 1 Yr. Growth %	14.18	-25.4	-13.68	2.69	-16.73
Tangible Book Value, 1 Yr. Growth %	201.33	-18.45	-11.51	40.45	31.48
Common Equity, 1 Yr. Growth %	-278.09	-27.46	-16.22	119.89	55.18
Cash From Operations, 1 Yr. Growth %	617.65	-36.42	67.3	-70.47	-19.56
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-110.24	-1.44T	-668.78	-118.94	62.55
Unlevered Free Cash Flow, 1 Yr. Growth %	577.99	-79.5	-559.8	-134.68	49.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-19.19	1.97	6.72	5.28	-23.55
Gross Profit, 2 Yr. CAGR %	-21.79	-3.81	9.02	4.77	-23.24
EBITDA, 2 Yr. CAGR %	12.92	76.46	14.34	-19.08	-16.4
EBITA, 2 Yr. CAGR %	10.37	57.81	14.71	-18.19	-19.92
EBIT, 2 Yr. CAGR %	10.37	87.31	14.71	-31.08	-19.92
Earnings From Cont. Operations, 2 Yr. CAGR %	57.41	123.54	-12.6	-33.89	-13.65
Net Income, 2 Yr. CAGR %	59.24	205.31	-12.41	-33.58	-13.67
Normalized Net Income, 2 Yr. CAGR %	63.95	513.08	3.84	-43.63	-27.09
Diluted EPS Before Extra, 2 Yr. CAGR %	-39.55	38.95	-40.9	-59.12	-41.65
Accounts Receivable, 2 Yr. CAGR %	-60.56	16.03	139.51	178.55	-
Inventory, 2 Yr. CAGR %	14.77	-10.8	-66.72	11.74	112.07
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.67	16.19	-37.53	-	-
Total Assets, 2 Yr. CAGR %	-1.04	-7.71	-19.76	-5.85	-7.53
Tangible Book Value, 2 Yr. CAGR %	75.55	56.76	-15.05	11.49	35.89
Common Equity, 2 Yr. CAGR %	19.53	13.66	-22.04	35.73	84.72
Cash From Operations, 2 Yr. CAGR %	40.69	113.6	3.14	-29.71	-51.26
Levered Free Cash Flow, 2 Yr. CAGR %	-	17.15	773.14	3.8	-53.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	17.89	-2.92	26.28	-34.87
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-11.68	3.93	5.36	-14.23
Gross Profit, 3 Yr. CAGR %	-	-14.28	2.23	4.16	-12.06
EBITDA, 3 Yr. CAGR %	-	12.65	53.7	-9.79	-6.59
EBITA, 3 Yr. CAGR %	-	10.6	43.43	-9.41	-8.75
EBIT, 3 Yr. CAGR %	-	23.99	43.43	-9.41	-18.6
Earnings From Cont. Operations, 3 Yr. CAGR %	-	44.35	46.5	-19.05	-22.3
Net Income, 3 Yr. CAGR %	-	45.2	80.94	-18.94	-22.05
Normalized Net Income, 3 Yr. CAGR %	-	66.85	186.24	-18.11	-30.78
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-28.51	-10.73	-45.89	-49.94
Accounts Receivable, 3 Yr. CAGR %	-	-20.39	33.54	193.04	-
Inventory, 3 Yr. CAGR %	-	-21.86	-37.57	-23.24	11.2
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-13.16	-13.74	-	-
Total Assets, 3 Yr. CAGR %	-	-9.94	-9.74	-12.88	-9.63
Tangible Book Value, 3 Yr. CAGR %	-	35.96	29.55	0.45	17.79
Common Equity, 3 Yr. CAGR %	-	1.2	2.67	10.15	41.92
Cash From Operations, 3 Yr. CAGR %	-	7.97	96.9	-32.02	-26.48
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	98.37	143.53	6.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	85.57	-31.11	24.94
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-5.25	-8.09
Gross Profit, 5 Yr. CAGR %	-	-	-	-7.12	-8.84
EBITDA, 5 Yr. CAGR %	-	-	-	-1.31	20.47
EBITA, 5 Yr. CAGR %	-	-	-	-1.97	13.6
EBIT, 5 Yr. CAGR %	-	-	-	-1.97	13.6
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	5.62	18.58
Net Income, 5 Yr. CAGR %	-	-	-	6.19	34.58
Normalized Net Income, 5 Yr. CAGR %	-	-	-	8.1	65.63
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-42.83	-24.7
Accounts Receivable, 5 Yr. CAGR %	-	-	-	31.38	-
Inventory, 5 Yr. CAGR %	-	-	-	-9.84	1.82
Total Assets, 5 Yr. CAGR %	-	-	-	-8.32	-8.86
Tangible Book Value, 5 Yr. CAGR %	-	-	-	25.58	32.05
Common Equity, 5 Yr. CAGR %	-	-	-	13.81	29.86
Cash From Operations, 5 Yr. CAGR %	-	-	-	-9.07	12.64
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	10.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	22.07